Skip to content

ERCP stenting in benign biliary stricture for resolution of Jaundice

FULLY COVERED SEMS VS MULTIPLE PLASTIC STENTS VS COMBINED STENTS TO TREAT BENIGN BILIARY STRICTURES : A MULTICENTRIC RANDOMISED CONTROLLED TRIAL (COMBS TRIAL) - NILL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103236
Enrollment
180
Registered
2026-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere

Interventions

Intervention1: Endoscopic retrograde cholangiopancreatography (ERCP): ERCP will be done in three groups with described intervention below. a) Fully covered Biliary SEMS b) Multiple plastic stents c) C

Sponsors

BSBY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age group - greater than or equal to 18 years 2)Symptomatic bile duct stricture (defined by cholangitis or persistent jaundice {Total bilirubin greater than or equal to 2.5mg/dl} for at least 1 month or persistent cholestasis associated with at least 3 times normal alkaline phosphatase levels) documented at time of enrolment for naive stricture or at the time of prior plastic stent placement in strictures that had 1 prior plastic stent inserted 3)Common bile duct stricture based on imaging assessment of dilatation of the common and/or intrahepatic bile ducts. 4)Benign etiologies like chronic pancreatitis, post cholecystectomy and idiopathic.

Exclusion criteria

Exclusion criteria: 1)Malignant bile duct stricture 2)A prior biliary metal stent or more than 1 plastic stent for 6 months 3)Stricture within 2 cm of common bile duct bifurcation 4)Portal cavernous cholangiopathy, 5)Known bile duct fistula or leak, 6)Symptomatic duodenal stenosis with gastric stasis, 7)Contraindication to endoscopic techniques or devices, 8)Refusal to consent

Design outcomes

Primary

MeasureTime frame
Safety profile and complication rates in all the 3 groups throughout the study period.Timepoint: At end of 2 years

Secondary

MeasureTime frame
To compare biliary stricture resolution 2 years after initial stent(s) defined as the absence of re- stenting after the stenting period and 2 years serum alkaline phosphatase level not exceeding twice the level at the end of the stenting period.Timepoint: at end of 2 years;To compare the technical success and treatment failure of stent placementTimepoint: At end of 2 years;Number of endoscopic retrograde cholangiopancreatography (ERCP) procedures during 2 years after initial stent placementTimepoint: At end of 2 years;Total number of stents placed during the study and duration of stent placement procedureTimepoint:

Countries

India

Contacts

Public ContactDr Ashok Jhajharia

Sawai Man Singh Medical college

drashokjhajharia@gmail.com09414236572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026